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Introduction: Venous thromboembolism (VTE) is a disease manifested as deep vein throm-
bosis and pulmonary embolism. General surgical procedures are associated with signiﬁcant
risk of precipitating VTE, and despite the surging evidences, it is often overlooked. The study
attempted at estimating the prevalence of VTE and bleeding risk factors coupled with the
adequacy of thromboprophylaxis administered.
Methodology: The study spanning 1-year duration was executed through collection of data
from patients older than 18 years, admitted to the general surgery department of a tertiary
care hospital. The data were collected using internally validated data collection form and the
appraisal of data was done using SPSS 18.
Results: Among the 400 subjects enrolled, number of patients in low, moderate, and high risk,
as per the Caprini score, was 24%, 35%, and 41%, respectively, with the difference being
signiﬁcant with p < 0.001. Bleeding risk was positive in 28% subjects and 36% received any
form of prophylaxis other than early ambulation. 28% subjects were identiﬁed to have
received adequate thromboprophylaxis.
Conclusion: Although the prevalence of 41% individuals at high risk for VTE is comparable to
the global prevalence of 41.5%, prophylactic adequacy of 28% was lower than the 33%
observed globally. Meticulous planning coupled with operational interventions, such as
institutional multidisciplinary thromboprophylactic team, can be an effective strategy at
enhancing the prophylactic standards and thereby attaining optimal patient outcomes.
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Thrombus comprising of platelets and ﬁbrin is the terminal
consequence of the blood coagulation pathway and helps
perpetuate hemostasis. Despite its beneﬁcial effect, it has the
potential to dislodge from the site of injury and occlude blood
vessels in other areas, producing a paradoxical effect.1 Venous
thromboembolism (VTE) is a disease that encompasses deep
vein thrombosis (DVT) and pulmonary embolism (PE). With
aptitude to produce signiﬁcant morbidity and mortality, they
jointly pose a global health concern. Oftentimes, VTE remains
asymptomatic and underdiagnosed, culminating in chronic
complications and truncated survival.
VTE is precipitated by several factors and humanity's
comprehension on its probable association with surgical
procedure is not novel. The patient at highest risk involves
those undergoing major orthopedic procedures, where 50–60%
patients have propensity to develop DVT.2 Although the
prophylaxis in orthopedic procedures is given due importance,
risk associated with general surgical procedures has been
consistently downgraded across the globe. A patient undergo-
ing major surgical procedure has 20-fold risk enhancement for
VTE and the risk is increased by 30% when there is absence of
optimal prophylaxis.3 The risk associated with VTE in general
surgery varies between 10 and 50% depending on the type of
surgery and patient risk factors.4 Accurate estimation of
thromboembolic risk is therefore quintessential and attempts
have been made since 1970s for fabrication of several risk
assessment models (RAMs) based on clinical and laboratory
parameters. Despite profuse RAMs available, none provided a
comprehensive guidance covering all patient groups.5
The increasing number of evidences accumulated through
meta-analysis studies has led to the development of American
College of Chest Physician (ACCP) 9th antithrombotic guide-
lines in 2013, which unlike its predecessor of 2008 has
distinctively emphasized the relevance of risk stratiﬁcation
by addressing nonorthopedic surgical thromboprophylaxis in
a separate section.6,7 The guideline advocates the use of
Caprini score8 as an effective RAM to appraise individualized
risk in general surgical candidates. Although it was not devised
using meticulous statistical procedures, it is relatively easy to
use and has been successful in discriminating different tiers of
risk among surgical patients. It has also been validated using a
large retrospective study comprising sample of general,
vascular, and urological surgery patients.9 However, Caprini
score has not been adequately validated in gynecological
surgery subjects and the application of the same to this
speciﬁc subgroup is unsubstantiated.
Although several studies have attempted to outline the
distribution of VTE risk in surgical patients, very few have
addressed the general surgical patients speciﬁcally. Estima-
tion of prevalence of VTE and bleeding risk factors can assist
healthcare practitioners contemplate on relevant issues with
thromboprophylaxis in the speciﬁc population and meticu-
lously plan strategies to tackle the same. The following study
was aimed at assessing various VTE and bleeding risk factors
prevalent in the population and the adequacy of prophylaxis
provided in relevance to the ACCP 9th antithrombotic guide-
lines.2. Materials and methods
The study spanning 1 year was carried out in the general
surgical department of a private tertiary care hospital in Kerala.
This cross-sectional study was conducted from February 2014 to
January 2015 and enrolled subjects greater than 18 years of age,
undergoing those surgical procedures, which are necessitated
with inpatient admission. Pregnant patients, patients of non-
Indian origin, those admitted solely for VTE treatment, or
operated under local anesthesia were excluded from the study.
Most of the local anesthesia procedures did not require
admission and were performed on a day care basis. Ethical
approval was obtained through written consent from the
institutional ethical committee prior to enrollment of the ﬁrst
subject. Verbal as well as written consent was obtained either
from the patients or relatives after duly informing them of the
various aspects as mandated in the ICMR ethical guidelines.10 A
total of 400 subjects were enrolled during the study period and
their demographics along with surgical data were collected
using an internally validated data collection form. Caprini score
was utilized for stratifying the patients into low-, moderate-,
and high-risk groups.8 Conditions, such as age 41–60 years,
swollen legs, varicose veins, minor surgery, sepsis <1 month
ago, history of inﬂammatory bowel disease, prior major surgery,
abnormal pulmonary function, obesity (deﬁned as BMI > 25 kg/
m2), and other comorbidities (diabetes, hypertension, coronary
artery disease, dyslipidemia), if present, were assigned 1 point
each. 2 points were assigned for the presence of each of these
conditions: age 61–74 years, laparoscopic surgery, major surgery
(>45 min duration), history or presence of malignancy, bed
conﬁnement >3 days, and central venous access. Age >75 years
and history of DVT were used to assign 3 points if present.
Similarly, multiple trauma and lower limb fractures were
assigned 5 points. The overall VTE risk score was assigned to
each patient and was estimated through summation of the
individual points assigned on the basis of presence of any of
these mentioned conditions.
Conditions, such as active bleeding, prior major bleeding,
known or untreated bleeding disorders, severe renal or hepatic
failure, thrombocytopenia, acute stroke, uncontrolled system-
ic hypertension, concomitant use of anticoagulants, antiplate-
let therapy, or thrombolytic drugs, were considered as risk
factors for bleeding, as per the ACCP recommendations.
Presence of these conditions was assumed as contraindica-
tions to administration of pharmacological prophylaxis. The
thromboprophylactic therapy administered to each patient
was scrutinized and compared against this guideline to
estimate the compliance. The recommendations used for
appraising the prophylactic compliance, as per the ACCP
guidelines, have been summarized in Table 1. Statistical
analysis of the data was performed using SPSS 18.0 and the
results were interpreted in terms of p-value with level of
signiﬁcance set at 0.05.
3. Results
An aggregate of 400 patients who met the predetermined
criteria were enrolled in the study. Among the total sample,
Table 1 – ACCP recommended venous thromboembolism prophylaxis in nonorthopedic surgical patients.
Caprini
score
Risk
level
Prophylaxis regimen
(without bleeding risk)
Prophylaxis regimen
(with bleeding risk)
0 Very low Early ambulation
1–2 Low Mechanical prophylaxis, preferably with IPC device
3–4 Moderate Any ONE of the following agents: Mechanical prophylaxis preferably with IPC device
 IPC device (min 20 h/day) or elastic stocking
 Unfractioned Heparin 5000 U s.c. TID
 Enoxaparin 40 mg s.c. OD
 Fondaparinux 2.5 mg s.c. OD
5 or more High Combination of the following agents: Mechanical prophylaxis, preferably with IPC device,
until risk of bleeding diminishes and pharmacologic
prophylaxis can be added
 IPC device (min 20 h/day) or elastic stocking
+ (any one of the following)
 Unfractioned Heparin 5000U s.c. TID
 Enoxaparin 40 mg s.c. OD
 Fondaparinux 2.5 mg s.c. OD
s.c., subcutaneous; OD, once-daily dosing; TID, thrice-daily dosing; IPC, intermittent pneumatic compression device.
Fig. 1 – Histogram representing frequency distribution of
bleeding risk factors.
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demonstrating a signiﬁcant difference in gender distribution
with p < 0.001. The mean age of the total sample was
determined at 50.09  16.52 years. Mean age of male popula-
tion was estimated to be 51.44  11.15 years and that of
females as 47.61  17.48 years. The difference in age distribu-
tion with respect to gender was found to be signiﬁcant with
p = 0.011. Majority of the subjects were found to belong to the
age group of 41–60 years (43%) with the least (7%) in age group
>74 years (Table 2). The distribution of males and females in
different age groups was found to be signiﬁcantly different
with p = 0.045.
The average height and weight of the population was
determined as 1.67  0.07 m and 65.69  10.2 kg, respectively.
The average BMI of the sample was found to be 23.4  3.5 kg/
m2 and the average length of hospital stay was estimated as
7.81  3.22 days. 4% (n = 16) of the subjects were underweight,
68% (n = 272) had normal weight, and the remaining 28%
(n = 112) were obese.
Major surgery deﬁned as procedures lasting >45 min using
general anesthesia was the most prevalent procedure encom-
passing 52% (n = 208) of the subjects. 20% (n = 80) underwent
laparoscopic surgery and the remaining 28% (112) had minor
surgery. The average duration of procedures was computed as
1 h 21 min  59 min. 44% (n = 176) underwent the procedure
under spinal anesthesia contrasting with 56% (n = 224), who
had general anesthesia, and the difference was signiﬁcant
with p = 0.019.
The average Caprini score of the enrolled subjects was
computed as 4.26  2.52 points. The number of patients in
low, moderate, and high risk, as per the Caprini score, was
24%, 35%, and 41%, respectively, with the difference being
signiﬁcant with p < 0.001. 29% of the patients on evaluation
were found to have bleeding risk factors with the most
prevalent being hepatic dysfunction encompassing 12% of
the total subjects (Fig. 1). The bleeding risk was found to be
8.3%, 37.14%, and 34.14% among low-, moderate-, and high-
risk patients, respectively, with the difference among groups
proving to be signiﬁcant with p < 0.0001. An extremely
signiﬁcant correlation was computed between Capriniscore and number of risk factors with Pearson correlation
coefﬁcient of 0.849. Similar correlation was found
between age and Caprini score with Pearson correlation
coefﬁcient of 0.456. However, correlation was also estimated
with bleeding risk factor and age yielding coefﬁcient
of 0.503.
Mobilization was used as sole strategy of prophylaxis in
64% subjects, whereas, at least some sort of prophylaxis using
mechanical and pharmacological modalities was done in the
remaining cases. Among them, mechanical prophylaxis was
administered to 14% patients, which comprised 5% subjects
receiving elastic compression stocking and 9% receiving
sequential compression device. Pharmacological prophylaxis
was relied for prophylaxis in 14% patients and consisted of 11%
receiving enoxaparin and the remaining 3% receiving low-
dose unfractioned heparin. Combination of both mechanical
and pharmacological prophylaxes was used only in 8% of the
patients. On comparing and contrasting the prophylactic
strategies with the standard guideline, it was estimated that
only 28% of the patients received optimal prophylaxis.
Prophylactic compliance with ACCP 9th guideline in each risk
category is represented in Fig. 2. Noncompliance with standard
prophylaxis was appraised as 65.52% among patients without
bleeding risk and 74.65% among patients having positive
bleeding risk. The difference was found to be nonsigniﬁcant,
with p = 0.065.
Fig. 2 – Compliance of prophylactic compliance to ACCP 9th
guideline in each risk category.
Table 2 – Patient risk factors for VTE and surgical
procedure distribution.
Risk factor for DVT Frequency
(number of
patients)
Percentage
(%)
1 point Caprini score risk factors
Age 41–60 years 172 43
Swollen legs 12 3
Varicose veins 12 3
Minor surgery 112 28
Sepsis <1month 60 15
History of IBD 4 1
Prior major surgery 12 3
Abnormal pulmonary function 36 9
Obesity
Other risk factors 160 40
2 point Caprini score risk factors
Age 61–74 years 76 19
Laparoscopic surgery 80 20
Major surgery 208 52
Malignancy present/previous 44 11
Bed conﬁnement >3 days 20 5
Central venous access 4 1
3 point Caprini score risk factors
Age >75 years 28 7
History of DVT 4 1
5 point Caprini score risk factors
Multiple trauma 4 1
Hip/pelvis/leg fracture 8 2
Surgical procedure
Drainage and debridement 68 17.0
Cholecystectomy 52 13.0
Appendectomy 48 12.0
Hernia repair 48 12.0
Exploratory laparotomy 28 7.0
Gastrectomy 16 4.0
Hemorrhoidectomy 16 4.0
Lords dilation 16 4.0
Thyroidectomy 16 4.0
Colostomy 12 3.0
Limb amputation 12 3.0
Mastectomy 12 3.0
Diagnostic laparoscopy 8 2.0
Fasciotomy 8 2.0
Fistulectomy 8 2.0
Anastomosis resection 4 1.0
Colectomy 4 1.0
Diaphragm repair 4 1.0
Orchiectomy 4 1.0
Proctectomy 4 1.0
Sclerotherapy 4 1.0
Skin grafting 4 1.0
Tracheostomy 4 1.0
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In this study, we assessed the prevalence of various risk
factors among the general surgical patients of a tertiary care
hospital for a period of 1 year. Since admissions in inpatient
general surgical department are usually made for patients
requiring surgery or necessity of surgery is evaluated, eachpatient will, therefore, have at least a minor risk for VTE, as per
the Caprini score.
The majority in the subject pool were men, similar to most
other similar studies with male dominance, and thus reducing
the risk factor in this population associated with use of
hormone preparations, such as oral contraceptives and
hormone replacement therapies. There was found to be
extremely signiﬁcant correlation between the number of risk
factors and Caprini score indicating that rather than single
dominant risk factors, presence of multiple minor factors was
responsible for the overall score. Although several RAMs are
available to estimate the risk of VTE, selection of an improper
one can underestimate the patient's risk and culminate in
inadequate thromboprophylaxis. Many surgeons tend to
perceive only obesity, immobilization, malignancy, and prior
VTE as potential threats and tend to overlook the minor
factors. These factors although may seem unsubstantial
individually, they may pose serious threats to the patients
in combination with underlying genetic deﬁciencies, which
are rarely screened for in India.
The data demonstrated correlation between age and overall
Caprini score, which necessitated more stringent monitoring
of elderly patients. However, the situation is further compli-
cated by the increase in bleeding risk factors with age, as
evident from the correlation between the two.
This may be attributed to the decline in hepatic function
with increasing age, which prevents the use of pharmacologi-
cal prophylactic measures in this age group. Elderly patients
should therefore be given adequate duration of mechanical
prophylaxis unless contraindicated, and monitoring should be
done at regular intervals to ensure compliance.
The study revealed that 41% patients were at high risk for
developing VTE. The prevalence was lower than the estima-
tion made through ENDORSE study by Pinjala et al.,11 where
61.3% surgical patients were at-risk. However, the later study
had also encompassed orthopedic surgical patients, which
may have increased the prevalence. The global surgical risk, as
estimated by Cohen et al.,12 accounted to 41.5% in surgical
patients and was comparable with the present study. In the
Indian subset ENDORSE study, the proportion of surgical
candidates provided with any kind of prophylaxis was
determined as 18.5%, of whom, 16.3% met the ACCP
recommended adequacy. It was observed in the current study
that 36% of the surgical patients were given at least some
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prophylaxis. Although these ratios were higher than the
Indian study, global ENDORSE study had estimated a greater
prophylaxis administration of 50.2% and up to 33% satisfying
adequacy criteria. European countries like Germany, Spain,
and Switzerland in contrast have been successful in achieving
appropriate prophylaxis rates of 92%, 82%, and 81%, respec-
tively.13–15 Such high rates have been achieved through
incorporation of computerized reminder systems in practice,
which is currently available in very few hospitals across India.
Another noteworthy ﬁnding is the complete noncompliance
estimated in low-risk patients. As per the ACCP recommenda-
tion, low-risk patients should be administered mechanical
prophylaxis preferably with sequential compression device,
which has not been practiced here. A recent study found that
despite timely ambulation, patients were still at risk of VTE,
and this risk was substantially reduced with mechanical or
pharmacological prophylaxis. Therefore, patient ambulation
or mobility should not be used as a reason to discontinue, or
restrict, prophylaxis during hospitalization.16
The major factor restraining the utilization of optimal
prophylaxis could be the lack of update with current guide-
lines. ACCP 9th guideline is more comprehensive than its prior
edition on which most surgeons rely to design prophylaxis.
Inadequacy may also be attributed to lack of individualization
of thromboprophylaxis. Patient discomfort associated with
mechanical prophylaxis, which mandate 20 h continuous
compression of the calf region, is also another probable factor
restraining surgeons from giving prophylaxis to low-risk
patients. Bleeding risk factor was positive in 28% of the
subjects and should not be considered as a curtailing
component as the guideline clearly states the type of
prophylaxis to be utilized in such a situation. The surgeon
was not apprehensive of the bleeding risk factors with
prophylactic doses of anticoagulants, especially enoxaparin,
as the incidence of adversities was perceived to be extremely
low. This is evident from the absence of any signiﬁcant
difference between noncompliance among patients with and
without bleeding risk. However, surgeons must exercise
caution while considering pharmacological prophylaxis in
patients with underlying bleeding risk, and should adhere to
the guideline to avoid adversities.
Formation of multidisciplinary thromboprophylaxis teams
comprising of physicians, clinical pharmacists, and nursing
staff can be a viable option to enhance the prophylactic
strategies in a country like India, where reliance on comput-
erized reminder system is not feasible across all settings. The
surgical nurse can make a detailed patient interview to
evaluate the VTE and bleeding risks in line with the standard
guidelines. The individualized score can then be communi-
cated to the clinical pharmacists, who, after weighing the risk
and beneﬁts of pharmacological versus mechanical prophy-
laxis, can make detailed recommendation to the physicians on
thromboprophylaxis for each surgical candidate.
5. Conclusions
The study triumphed in estimating the prevalence of risk
factors associated with VTE in the study setting. Hepaticdysfunction was the most prevalent bleeding risk factor and
its association with increasing age presents a potential
complication in administering proper prophylaxis. Physi-
cians should restrain from using early ambulation as the sole
prophylactic strategy. The thromboprophylaxis  adequacy,
although comparable to global estimates, still has scope for
enhancement through meticulous planning and appropriate
interventions.
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